Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by uchuckon May 14, 2015 12:06pm

161 Views

Post# 23728661

Mr. McWhirter, Selective Asset Management

is a huge fan of PLI, he's on BNNTV MarketCall within 48 hours or so, I'm going to put in a "stink bid" of $2.45 in case he ascribes it a a "top pick."

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features